Preliminary Efficacy of Occupational Therapy Integrating Horses on Self-regulation in Youth With Autism
2 other identifiers
interventional
72
1 country
1
Brief Summary
The goal of this clinical trial is to learn about occupational therapy integrating horses for autistic youth. The main questions it aims to answer are:
- Does occupational therapy integrating horses improve self-regulation in autistic youth
- Does occupational therapy integrating horses affect salivary cortisol and alpha-amylase Participants will receive 10 weeks of occupational therapy, and will be asked to provide saliva samples each week. Researchers will compare occupational therapy integrating horses to occupational therapy in a clinic to see if integrating horses affects self-regulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 21, 2023
CompletedFirst Submitted
Initial submission to the registry
April 7, 2023
CompletedFirst Posted
Study publicly available on registry
May 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedResults Posted
Study results publicly available
October 2, 2026
CompletedOctober 2, 2026
August 1, 2026
2.1 years
April 7, 2023
July 29, 2026
September 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Hyperactivity
The Hyperactivity subscale of the Aberrant Behavior Checklist, Second Edition (ABC-2) measures parent/caregiver-reported hyperactive and impulsive behaviors, including excessive activity, impulsivity, and difficulty remaining still or attending. The subscale consists of 16 items, with total scores ranging from 0-48. Higher scores indicate greater hyperactivity and more severe behavioral difficulties, while lower scores indicate less hyperactivity and better behavioral functioning. Item scores are summed to produce the subscale score.
Week 1 & Week 10
Secondary Outcomes (8)
Change in Irritability
Week 1 & Week 10
Change in Emotional Reactivity
Week 1 & Week 10
Change in Dysphoria
Week 1 & Week 10
Change in Concentration of Salivary Cortisol
Pre-session, Post-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10
Change in Concentration of Salivary Alpha-amylase
Pre-session, Within-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10
- +3 more secondary outcomes
Study Arms (2)
Occupational Therapy Integrating Horses
EXPERIMENTAL10 weeks of occupational therapy focused on self-regulation skills, provided while participants are riding horses
Occupational Therapy in a Clinic
ACTIVE COMPARATOR10 weeks of occupational therapy focused on self-regulation skills, provided in a traditional clinic environment
Interventions
10 weeks of occupational therapy focused on teaching and practicing self-regulation skills, provided while participants are riding horses
10 weeks of occupational therapy focused on teaching and practicing self-regulation skills, provided in a traditional clinic
Eligibility Criteria
You may qualify if:
- meet clinical cut-offs for ASD on the Autism Diagnostic Observation Schedule, Second Edition(ADOS-2) and Social Communication Questionnaire (≥ 11)
- nonverbal IQ≥65 on Leiter International Performance Scale Third Edition (Leiter-3)
- verbally fluent defined by meeting standard administration criteria for ADOS-2 module 3
- score \>10 on the irritability subscale of the aberrant behavior checklist
- able to tolerate a helmet and ride a horse for 10 minutes while following safety rules
- and able to provide a saliva sample
You may not qualify if:
- weigh more than 200 pounds
- smoke or regularly use steroids
- receive outpatient occupational therapy
- have 10+ hours horseback riding experience in the previous 6 months
- history of animal abuse or phobia of horses
- have a sibling previously enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Temple Grandin Equine Center
Denver, Colorado, 80216, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
This study was underpowered to detect many of the observed between-group effect sizes as the original power analysis estimated medium-large effect sizes. Finally, the study is limited by the high drop-out rate from the OT-ZOR Clinic intervention, and the resulting 2:1 randomization (Clinic: Equine) may have biased the sample with participants well-suited for the Clinic condition.
Results Point of Contact
- Title
- B. Caitlin Peters
- Organization
- Colorado State University
Study Officials
- PRINCIPAL INVESTIGATOR
Brittany C Peters, PhD
Colorado State University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The research assistant that rates goal attainment at the conclusion of therapy will be asked to participants' intervention assignment (OTEE HORS v OT Clinic).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2023
First Posted
May 6, 2023
Study Start
March 21, 2023
Primary Completion
April 23, 2025
Study Completion
November 1, 2025
Last Updated
October 2, 2026
Results First Posted
October 2, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ICF
- Time Frame
- We will share in an appropriate data repository indefinitely, no later than the acceptance for publication of the main findings from the final dataset
De-identified data will be shared in an appropriate data repository, such as the "Data and Specimen Hub" (DASH) or the "National Database for Autism Research" (NDAR). Data will be shared no later than the acceptance for publication of the main findings from the final dataset. Salimetrics will discard saliva samples after testing, and therefore saliva samples will not be available for sharing.